Metropolis
Lots of interest in Metropolis, but we want a strategic fit: MD Ameera Shah
In a Q&A, the promoter and MD of the company talks about how the dynamics are changing in the diagnostics sector post Covid, and outlines her strategy for Metropolis 3.0
 "Lots of interest in Metropolis, but we want a strategic fit: MD Ameera Shah")
Here's why HDFC Securities recommends buying Metropolis, Zensar Tech
Vinay Rajani of HDFC Securities is bullish on Metropolis, Zensar Tech.
 "Here's why HDFC Securities recommends buying Metropolis, Zensar Tech")
Labouring under illusions
The development of Haryana's golden goose has thrived despite reflecting all the worst contradictions of post-liberalisation India
 "Labouring under illusions")
Diagnostic players ride on changes in health insurance to beat slowdown
Metropolis, Dr Lal and Thyrocare are likely to see more gains led by expansion, increasing penetration, preventive testing and government's Ayushman Bharat scheme
 "Diagnostic players ride on changes in health insurance to beat slowdown")
Metropolis IPO: Valuations factor in all the positives
Price caps on tests and competitive nature of the sector could test the high valuations
 "Metropolis IPO: Valuations factor in all the positives")
Metropolis' Ameera Shah resists IPO
Metropolis has 1,200 collection centres and a presence in six countries
 "Metropolis' Ameera Shah resists IPO")
Path lab chain Metropolis plans acquisitions in India, abroad
The Rs 650 cr firm, in which PE nvestor Carlyle holds 30%, will opt for an IPO or Private equity to finance acquisition
 "Path lab chain Metropolis plans acquisitions in India, abroad")
